Relmada Therapeutics (RLMD) Other Accumulated Expenses (2013 - 2026)
Relmada Therapeutics (RLMD) recorded Other Accumulated Expenses of $76,100 in Q1 2026, up 12.6% from $67,600 a year earlier but down 43.4% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics reported Other Accumulated Expenses of $134,400, up 3.9% from FY2024.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $129,400 in FY2024 (+12.0%) and $115,500 in FY2023.
- Quarterly Other Accumulated Expenses has ranged from $67,600 in Q1 2025 to $134,400 in Q4 2025 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses has increased for three consecutive quarters, with growth averaging 7.3% over the last four quarters.
- Per Business Quant, the preceding three quarters came in at $134,400 (Q4 2025), $80,900 (Q3 2025) and $79,400 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Relmada Therapeutics | 384.01 Mn | 384.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 76,100.00 |
| Dec 31, 2025 | 134,400.00 |
| Sep 30, 2025 | 80,900.00 |
| Jun 30, 2025 | 79,400.00 |
| Mar 31, 2025 | 67,600.00 |
| Dec 31, 2024 | 129,400.00 |
| Sep 30, 2024 | 80,300.00 |
| Dec 31, 2023 | 115,500.00 |
| Dec 31, 2020 | 126,200.00 |
| Jun 30, 2020 | 65,900.00 |
| Dec 31, 2019 | 92,900.00 |
| Sep 30, 2019 | 65,200.00 |
| Jun 30, 2019 | 59,400.00 |
| May 31, 2013 | 275.00 |
API Access
Relmada Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();